|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| PharmaVitae Japanese Comparator Tool |
|
|
|
|
€ 18 240,00 |
Editeur
: |
Datamonitor |
Langue
: |
Anglais |
Date de publication : |
Février 2005 |
Taille du document : |
N/A |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
The Japanese Pharmaceutical Market Outlook 2001
142 pages | Août 2001 |
Although Japan is the second largest pharmaceutical market in the world, it has traditionally been a relative 'no-go' area for pre-eminent Western drug companies.
Now, however, extensive cultur |
1 200,00 €
|
| |
| |
OTC Analgesics in Germany
15 pages | Juillet 2002 |
The German market for OTC analgesics growth not so rapidly and reached a value of Euro 772 million (US$ 729 million) in 2001, an increase of 1.6% on the previous year.
Over the review period, the m |
198,00 €
|
| |
| |
Top Ten and Emerging Pharmaceutical markets
214 pages | Juillet 1999 |
Introduction : Provides the background to the report by identifying the major trends within global healthcare markets and how these interact and influence the markets for pharmaceuticals.
Mar |
795,00 €
|
| |
| |
The Pharmaceutical Industry Online
88 pages | Juillet 2002 |
In the United States, eMarketer projects that business-to-business e-commerce trade will grow to $1.3 trillion by 2005, while online trade in the health car |
800,00 €
|
| |
| |
The Drug Delivery Outlook 2001
176 pages | Juillet 2001 |
In an environment where there is constant pressure to launch new products onto the market, the cost of investment in drug delivery compares very favourably with new drug discovery.
Subseque |
955,00 €
|
| |
| |
The Evolution of DTC marketing across key pharmaceutical markets
152 pages | Mars 2000 |
Pharmaceutical companies mainly market their products through contact between their sales force and heathcare providers.
However, due to the nature of its products, the pharmaceutical industry |
955,00 €
|
| |
| |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century
189 pages | Octobre 2000 |
The Drug Discovery Outlook: Drivers of innovation in the 21st Century introduces and analyzes the five key enabling technologies and bioinformatics, which are currently driving pharmaceutical dru |
955,00 €
|
| |
| |
The Pharmaceutical Industry Paradox: A strategic analysis of the countertrends of consolidation and fragmentation
128 pages | Mai 2002 |
The pharmaceutical industry currently represents a huge paradox.
Whilst the pursuit of critical mass has driven consolidation and brought about the creation of mega-companies such as Pharmacia, Gla |
953,48 €
|
| |
| |
Chinese Markets for Pharmaceuticals
225 pages | Janvier 2002 |
China's demand for pharmaceuticals has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's economic |
2 835,00 €
|
| |
| |
The Pharmaceutical Profitability Outlook
150 pages | Février 1999 |
Is pharmaceutical profitability sustainable into the 21st century? “As the pharmaceutical industry finds itself at a crossroads, the strategic directions companies take will be pivotal in determini |
795,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| PharmaVitae Japanese Comparator Tool |
|
|
Introduction
Datamonitor's PharmaVitae Japanese Comparator Tool builds from the PharmaVitae profiles included in the report 'Japanese Pharma to 2010'. This new tool allows you to compare the 15 leading players in this market by current and forecast sales by therapy area. At a strategic level, compare companies by generic risk, R&D dependence and segment portfolios by age, value and source of products
Reasons to Purchase
Access continuously tracked data on the leading players and treatments in the Japanese pharmaceutical market analyzing current and future trends
Compare players by US or global forecast therapy area sales and portfolio breakdown measures to identify winners and losers to 2010
Drill down to the individual drug forecast level for each company, identifying the key drivers behind forecast performance over the next seven years
|
|
|
PPLSEN
|
|
|
|
|
